SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-021246
Filing Date
2017-11-02
Accepted
2017-11-02 16:37:37
Documents
49
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnat-10q_20170930.htm 10-Q 920064
2 EX-23.1 cnat-ex231_355.htm EX-23.1 2400
3 EX-31.1 cnat-ex311_6.htm EX-31.1 10753
4 EX-31.2 cnat-ex312_11.htm EX-31.2 10801
5 EX-32.1 cnat-ex321_7.htm EX-32.1 6838
6 EX-32.2 cnat-ex322_10.htm EX-32.2 6926
  Complete submission text file 0001564590-17-021246.txt   3737504

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cnat-20170930.xml EX-101.INS 721952
8 XBRL TAXONOMY EXTENSION SCHEMA cnat-20170930.xsd EX-101.SCH 29490
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20170930_cal.xml EX-101.CAL 37095
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20170930_def.xml EX-101.DEF 100072
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20170930_lab.xml EX-101.LAB 268025
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20170930_pre.xml EX-101.PRE 200001
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 171172988
SIC: 2834 Pharmaceutical Preparations